Keywords: Breast cancer, invasion, basement membrane, metaplasia, matrix metalloproteinase Abbreviations: 3DlrBM, three-dimensional laminin-rich basement membrane; 2D, two-dimensional monolayer; MMP, matrix metalloproteinase; siRNA, small inhibitory RNA; RT-PCR, reverse transcript polymerase chain reaction Abstract A crucial step in human breast cancer progression is the acquisition of invasiveness. There is a distinct lack of human cell culture models to study the transition from pre-invasive to invasive phenotype as it may occur 'spontaneously' in vivo. To delineate molecular alterations important for this transition, we isolated human breast epithelial cell lines that showed partial loss of tissue polarity in three-dimensional reconstituted-basement membrane cultures. These cells remained non-invasive; however, unlike their non-malignant counterparts, they exhibited a high propensity to acquire invasiveness through basement membrane in culture. The genomic aberrations and gene expression profiles of the cells in this model showed a high degree of similarity to primary breast tumor profiles. The xenograft tumors formed by the cell lines in three different microenvironments in nude mice displayed metaplastic phenotypes, including squamous and basal characteristics, with invasive cells exhibiting features of higher grade tumors. To find functionally significant changes in transition from pre-invasive to invasive phenotype, we performed attribute profile clustering analysis on the list of genes differentially expressed between pre-invasive and invasive cells. We found integral membrane proteins, transcription factors, kinases, transport molecules, and chemokines to be highly represented. In addition, expression of matrix metalloproteinases MMP-9,-13,-15,-17 was up regulated in the invasive cells. Using siRNA based approaches, we found these MMPs to be required for the invasive phenotype. This model provides a new tool for dissection of mechanisms by which pre-invasive breast cells could acquire invasiveness in a metaplastic context.
Introduction
Breast carcinomas are phenotypically and behaviorally heterogeneous (1) . Subtypes of breast cancer with distinct behavioral characteristics have been recognized morphologically as well as by molecular analyses. For all breast cancers, conversion to the invasive phenotype is distinct from metastasis but is an obligate prerequisite for metastasis thus representing a crucial step in cancer progression. Molecular profiling studies have begun to determine markers that are associated with progression in different breast cancer subtypes (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) . Relevant models that recapitulate the morphological and molecular aspects of progression within subtypes are needed to determine which of these molecular changes function in acquisition of the invasive phenotype.
Culture models of human breast cells could provide such an opportunity if relevance to cancer progression in vivo were established. Pathways associated with transition to malignancy have traditionally been studied using either transgenic mouse models or primary human cells engineered to express genes with oncogenic properties. To deal with the heterogeneity of human breast tumors, cell lines originating from a large number of malignant breast carcinomas have been employed (18) . It would be useful also to have models of 'spontaneous' transition to malignancy -as opposed to transgenic-which could include intermediate non-invasive and pre-invasive stages of carcinogenesis -as opposed to modeling only the invasive carcinoma stage. Such models could facilitate the discovery of steps in progression to the invasive phenotype in a context which recapitulates more of the complexity of carcinogenesis.
The HMT-3522 human breast epithelial cell line series (S1, S2, and T4-2) were derived from a reduction mammoplasty specimen of a patient with fibrocystic breast disease more than 20 years ago. The epithelial component of the tissue was grown in defined medium to give rise to S1 cells that became immortalized spontaneously; these cells are EGF-dependent for growth and are non-tumorigenic (19) . Continuous culturing in the absence of EGF gave rise to a cell population referred to as S2, a cell line that is heterogeneous and essentially still non-malignant (20) . Frequent inoculation of S2 cells into mice eventually produced a rare tumor which was cultured and passaged again through mice (20) . The cell line derived from this tumor is referred to as T4-2 (20) . Previously, we designed a three dimensional lamininrich basement membrane (3DlrBM) assay to model both the normal breast and breast cancers (21) ( Figure   1A ). In 3DlrBM, S1 cells produce growth-arrested acini that express differentiation markers mimicking in vivo polar patterns of localization of a number of markers (21) : S2 colonies are heterogeneous (this report), and T4-2 cells form large and disorganized colonies (22) .
Here, we isolated three essentially homogeneous cell populations from S2 cells which we refer to as S3-A, S3-B, and S3-C using colony size in 3DlrBM as a screening tool ( Figure 1A ). These cells were noninvasive but had a higher potential for acquiring invasiveness than the parent S2. We found a substantial number of similarities between the model of S3 vs. T4-2 and pre-invasive to invasive transition in breast carcinogenesis based on progressive loss of tissue polarity, ability to form tumors with squamous and basal metaplastic histology, 76% similarity to recurrent CGH abnormalities found in breast tumors, and gene expression changes in classes of genes previously identified as being important for malignancy and invasion. These observations establish the S3 cell lines as the pre-invasive counterpart of a model of breast cancer progression within a metaplastic context. Using matrix metalloproteinases we demonstrate the utility of this model in identifying functionally significant changes in transition from the pre-invasive to the invasive phenotype in metaplastic breast cancer. The usefulness of the model is demonstrated further in another report (23) which describes the discovery of a novel pathway involved in invasion using this progression series.
Materials and Methods
Cell culture. S1 and T4-2 cells were grown in tissue culture monolayers (2D) using Falcon TM tissue culture plastic or 3D in lrBM (Matrigel TM ) in defined medium as described previously (21, 22) , S2 and S3 cells were grown under the same conditions as T4-2.
Indirect immunofluorescence analysis and image acquisition in 3DlrBM. Cells in 3DlrBM were embedded in sucrose and frozen on dry ice in Tissue-Tek OCT (Miles Laboratories), sectioned and immunostained as described previously (22) .
Comparative Genomic Hybridization (CGH).
Chromosomal CGH and BAC array CGH were performed essentially as described previously (24) . Hierarchical clustering analysis was performed with
GeneSpring software (Silicon Genetics), using standard correlation with a minimum distance metric of 0.001 to determine relatedness of cell lines. This was done using both the chromosomal and the BAC array data, with only significant amplification/deletion data points, as well as with the complete datasets, producing comparable results.
Analysis of tumor formation in vivo.
We injected the cells into female balb/c athymic nude mice (Simonsen laboratories), measured tumors weekly using a calipher, and graphed the tumor frequency and volumes of tumors taken out after 9-10 weeks of tumor growth at which time the animals were sacrificed. Global mRNA expression analysis by cDNA microarrays. cDNA microarrays with ~8000 known gene spots on poly-L-lysine-coated chips (custom arrayed at LBNL using Research Genetics 8k human clones)
were used. mRNA samples were directly compared to each other by co-hybridization to the same slide using dendrimer technology to label with red-Cy5 or green-Cy3 (Genisphere). Total RNA (1µg) isolated with Qiagen RNEasy reagents was used for each sample hybridized. Cells in 3DlrBM were extracted using 5mM EDTA in cold PBS to dissolve the Matrigel™. For each comparison, 3 independent sets of cultures were processed, and cells were examined at day 10 of culture. For each comparison, 4 slides were hybridized. This corresponded to 3 sets of RNAs from independent cultures plus a dye-swap experiment in which the red and green label was switched for the two samples in question. Data were analyzed as described in SF 8.
RT-PCR. 1-Quantitative. The RNA prepared for microarrays was used to prepare cDNA after DNAse I (Invitrogen) treatment, using Superscript First-Strand Synthesis System for RT-PCR (Invitrogen).
Quantitative real time PCR was done using Lightcycler (Roche) and FastStart SYBR Green (Roche). allowed us to obtain data relevant to intact cells only, FITC fluorescence peak was evaluated for its median value and was corrected using samples that had not been treated with primary antibody.
Gelatin zymography. Conditioned medium (for 48 hrs) from 10 day cultures of S1, S2, S3, and T4-2 were used. Samples were analyzed by SDS-PAGE zymography (25) to determine the molecular weights and the relative abundance of the gelatinases present.
Invasion assay. The ability to invade through lrBM (Matrigel™) was measured in Boyden chamber assays, essentially as described (26) . and counterstained with hematoxylin, followed by dehydration in 70% ethanol, 95% ethanol, 100%
ethanol, Xylene, and coverslips mounted using Permount (Fisher Scientific, SP15). Strong nuclear staining was scored as positive and %Ki67 positive nuclei were determined for at least three tumor areas for each cell type injection, counting a minimum of 100 cells per area. p63. Immunohistochemistry was performed essentially as described for Ki67, except for omitting the trypsin step in antigen retrieval and increasing hydrogen peroxide blocking to 15 minutes. Primary antibody (Lab Vision, p63 Ab-1 clone 4A4) was used at 2µg/ml. CK5/6, ER, PR. Immunohistochemistry was performed as described in (27) using CK5/6 primary antibodies from Zymed (1:100), ER from DAKO (1:25) and PR from DAKO
(1:200) and for HER2-neu, the Herceptest kit from DAKO was used.
Results

S3 cells display partial loss of tissue polarity in 3DlrBM, and a pre-invasive phenotype
Using colony size in 3DlrBM as an initial screen, we isolated multiple small, medium, and large sized colonies, expanded and propagated these clones for at least six generations, and examined their morphology in the 3D assay ( Figure 1B ). We chose three isolates that essentially bred true for the size of colony formed. We refer to these as S3-A, S3-B, and S3-C cell lines where colony size is A<B<C. S3-A cultures contain ~10% very large colonies (not shown); otherwise the colony size, especially for S3-C's, is essentially homogeneous. S3 cells displayed intermediate phenotypes compared to S1 and T4-2 colonies in 3DlrBM, as determined by markers that have been used extensively to describe tissue (acinar) polarity (22, (28) (29) (30) (31) such as basolateral expression of β catenin, basal β4 integrin, cortical actin, and Ki67 labeling ( Figure 1C ). In Boyden Chamber assays S1, S2, and S3 cell lines did not invade lrBM but T4-2 cells were invasive ( Figure 1D ). When conditioned-medium (CM) from T4-2 cells was added to the chambers, S1 and S2 cells, they did not invade whereas S3-A, S3-B, and S3-C became invasive with the S3-C cells displaying the highest propensity to invade: T4-2>C>B>A.
S3 cells display an intermediate potential to form tumors.
We determined tumorigenicity of the cells when injected into nude mice under three different microenvironments: in the flank with cells alone or cells plus Matrigel, and into mammary fat pads with cells alone (Figure 2 ). In none of the injections did S1 cells or media control produced any measurable growth but T4-2 cells formed palpable tumors at high frequency as shown also previously (20, 22, 32, 33) ( S3s. The fat pad tumor histology also showed similarities to squamous metaplasias of the breast ( Figure   2J , SF 1D) with T4-2 tumors being higher grade in general, based on the degree of differentiation, soft tissue involvement, and calcification phenotypes.
S3 cells display genomic aberrations that are distinct from those found in S1 and T4-2, but are relevant to some human breast cancers. We determined the genomically amplified or deleted regions by comparative genomic hybridization (CGH) (SF 2). The number of aberrations increased progressively when S1, S2-S3 and T4-2 cells were compared ( Figure 3A-B) . Hierarchical clustering analysis ( Figure   3C ) showed that the S2-S3 and T4-2 cell lines were more closely related to each other than they were to the S1 cells, and that the malignant T4-2 chromosomal aberration profiles were distinct from those of the S2-S3 cells. S2, S3, T4-2 cell lines contained 76% (22 of 29) of the chromosomal gains or losses that are reported to be commonly found in primary breast tumors ( Figure 3D ). Of the aberrations recurrently found in carcinoma in situ (pre-invasive), 6/10 were present in S3-A, S3-B, and S3-C cells; but all 10
were found in T4-2. The aberrations that were present in T4-2 but not in S3 were those found in high grade in situ or invasive carcinomas. confirmed these results using quantitative RT-PCR ( Figure 4A ) and western blots of CM (not shown). For the membrane-bound MMP15 and MMP17, FACS analysis showed that cell surface expression was higher in T4-2 than in S3-C cells ( Figure 4B-C) . MMP15 has been shown to activate proMMP2 by cleavage (37) . Therefore, we determined overall gelatinolytic activity, including MMP2 and MMP9 activity, present in S1, S2, S3, and T4-2 cell lines using zymograms. S1 cells expressed proMMP2 but not MMP9; S2, S3-A, S3-B had no detectable expression of MMP2 or MMP9; S3-C had a small amount of proMMP9 expression and T4-2 showed high levels of proMMP9 but no MMP2 expression ( Figure 4D ).
In this model, we could directly assess the significance of MMP expression changes for the invasive phenotype. A broad-spectrum MMP inhibitor, GM6001 (38), abrogated T4-2 invasiveness whereas treatment of cells with C1004 an inactive analog of GM6001, had no detectable effect ( Figure 5B ). To confirm the inhibitor data specifically, we used siRNAs to transiently and individually knock down the levels of MMP9, 13, 15, and 17 ( Figure 5A ) and found that siRNAs which successfully knocked down these MMPs decreased the amount of invasiveness of T4-2 cells compared to the scrambled control siRNA ( Figure 5C ). MMPs were important for acquisition of invasiveness in S3-C cells as well: addition of GM6001, and not the control C1004, to either the S3-C or T4-2 media (the CM was taken from the latter) inhibited the ability of the T4-2 CM to induce invasiveness in S3-C ( Figure 5D ).
Discussion
Modeling human breast cancer in culture traditionally has relied on carcinoma-derived cell lines or (46) . In addition to the rare pure squamous carcinomas of the breast, 39% of breast cancers in premenopausal African-Americans and the majority of tumors in BRCA1 mutation carriers are ER-PR negative, and have basal characteristics (47, 48) . Understanding whether such similarities in marker expression translate to overlap in the mechanism of transition to invasiveness would require developing models that recapitulate these subtypes, as described for at least one subtype developed here. Here we have described this model as one of transition from pre-invasive to invasive phenotype, to mimic the multi-step carcinogenesis hypothesis of breast cancer (50, 51) . However, the emerging cancer stem/ progenitor cell hypothesis also needs to be considered. Sontag and Axelrod have proposed four separate models to describe how atypical hyperplasia, ductal carcinoma in situ, invasive ductal carcinoma and metastasis may relate to each other (1) . These are the linear, non-linear, branched, and parallel pathways.
Unlike the other three hypotheses, the parallel pathway does not assume that in situ carcinoma develops into invasive carcinoma, but rather that in situ and invasive carcinomas can arise from the same progenitor. In our cell lines, S2 gave rise to both the pre-invasive S3-C and the invasive T4-2 cells via different steps of manipulation in culture and in mice, respectively ( Figure 1A) . Therefore, it is tempting to speculate that the model described here could be placed as supporting the parallel progression specific genes for certain subtypes of cancers may eliminate non-specific effects, thereby producing more desirable clinical outcomes (55) . In addition to the list of genes differentially expressed between S3-C and T4-2 ( Table 1, 
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